A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes

AIDS Research and Human Retroviruses

Volumn 13, Issue 17, 1997, Pages 1525-1532

  Comardelle, Alla M ^a   Norris, Charles H ^a,b   Plymale, Douglas R ^a   Gatti, Paul J ^b   Choi, Bongkun ^b   Fermin, César D ^a,b   Haislip, Allyson M ^b   Tencza, Sarah Burroughs ^c   Mietzner, Timothy A ^c   Montelaro, Ronald C ^c   Garry, Robert F ^a,b  

^a TULANE UNIVERSITY   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELITTIN; MEMBRANE PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; CELL MEMBRANE PERMEABILITY; CYTOLYSIS; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; XENOPUS LAEVIS;

EID: 0030806588     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1997.13.1525     Document Type: Article

References (67)

1. Fermin CD and Garry RF: Membrane alterations linked to early interactions of HIV with the cell surface. Virology 1992;191: 941-946.
2. Rasheed S, Gottlieb AA, and Garry RF: Cell killing by ultraviolet-inactivated human immunodeficiency virus. Virology 1986; 154:395-400.
3. Volsky DJ, Zeira M, and Loyter A: The mechanism of human immunodeficiency virus type 1 entry and fusion as determined by fluorescence dequenching. In: Membrane Interactions of HIV (Aloia R and Curtain C, eds.). Wiley-Liss, New York, 1992, pp. 167-186.
4. Garry RF: Potential mechanisms for the cytopathic properties of human immunodeficiency virus. AIDS 1989;3:683-684.
5. Gallaher WR, Fermin CD, Henderson LA, Montelaro RC, Martin A, Qureshi MN, Ball JA, Luo-Zhang H, and Garry RF: Membrane interactions of HIV: Attachment, fusion and cytopathology. Adv Membrane Fluidity 1992;6:113-142.
6. Levy JA: Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
7. Voss TG, Fermin CD, Levy JA, Vigh SG, Choi B, and Garry RF: Alteration of intracellular sodium and potassium concentrations correlates with induction of cytopathic effects by human immu-nodeficiency virus. J Virol 1996;70:5447-5454.
8. Makutonina A, Voss TG, Plymale DR, Fermin CD, Norris CH, Vigh SG, and Garry RF: Human immunodeficiency virus infection of T-lymphoblastoid cells reduces intracellular pH. J Virol 1996;70:7049-7055.
9. Voss TG, Gatti PG, Fermin CD, and Garry RF: Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl- cotransporter. Virology 1996; 219:291-294.
10. Garry RF, Gottlieb AA, Zuckerman KP, Pace JR, Frank TW, and Bostick DA: Cell surface effects of human immunodeficiency virus. Biosci Rep 1988;8:35-48.
11. Garry RF, Kort JJ, Koch-Nolte F, and Koch G: Similarities of viral proteins to toxins that interact with monovalent cation channels. AIDS 1991;5:1381-1384.
12. Cao J, Park I-W, Cooper A, and Sodroski J: Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J Virol 1996;70:1340-1354.
13. Cheng-Mayer C, Quiroga M, Tung M, Dina D, and Levy J: Viral determinants of HIV-1 T-cell or macrophage tropism, cytopathogenicity, and CD4 modulation. J Virol 1990;64:4390-4398.
14. York-Higgins D, Cheng-Mayer C, Bauer D, Levy JA, and Dina D: Human immunodeficiency virus type 1 cellular host range, replication, and cytopathicity are linked to the envelope region of the viral genome. J Virol 1990;64:4016-4020.
15. Fisher A, Ratner L, Mitsuya H, Marselle L, Harper M, Broder S, Gallo R, and Wong-Staal F: Infectious mutants of HTLV-III with changes in the 3′ region and markedly reduced cytopathic effects. Science 1986;233:655-659.
16. Lee S, Hu W, Fisher A, Looney D, Kan V, Mitsuya L, Ratner L, and Wong-Staal F: Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. AIDS Res Hum Retroviruses 1989;5:441-449.
17. Wilk T, Pfeiffer T, and Bosch V: Retained in vitro cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 1992;189:167-177.
18. Eisenberg D and Wesson M: The most amphiphilic alpha-helices include two amino acid segments in human immunodeficiency virus. Biopolymers 1990;29:171-177.
19. Miller MA, Garry RF, Jaynes JM, and Montelaro RC: A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides. AIDS Res Hum Retroviruses 1991;7:511-519.
20. Venable RM, Pastor RW, Brookes BR, and Carson FW: Theoretically determined three-dimensional structures for amphipathic segments of the HIV-1 gp41 envelope protein. AIDS Res Hum Retroviruses 1989;5:7-22.
21. Miller MA, Cloyd MW, Liebmann J, Rinaldo CR Jr, Islam KR, Wang SZ, Mietzner TA, and Montelaro RC: Alterations in cell membrane permeability by the lentivirus lytic peptide (LLP-1) of HIV-1 transmembrane protein. Virology 1993;196:89-100.
22. Srinivas S, Srinivas R, Anantharamaiah G, Segrest J, and Compans R: Membrane interactions of synthetic peptides corresponding to amphipathic helical segments of the human immunodeficiency virus type-1 envelope glycoprotein. J Biol Chem 1992;267: 7121-7127.
23. Chernomordik L, Chanturiya A, Suss-Toby E, Nora E, and Zimmerbug J: An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J Virol 1994;68:7115-7123.
24. Zasloff M, Martin B, and Chen H-C: Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci USA 1988;85:910-913.
25. Cornut I, Thiaudiere E, and Dufourcq J: The amphipathic helix in cytotoxic peptides. In: The Amphipathic Helix (Epand RM, ed.). CRC Press, Boca Raton, Florida, 1993, pp. 174-219.
26. Tencza SB, Miller MA, Islam K, Mietzner TA, and Montelaro RC: Effect of amino acid substitutions on calmodulin binding and cytolytic properties of the LLP-1 peptide segment of HIV-1 transmembrane protein. J Virol. 1995;69:5199-5202.
27. Gawrisch K, Han K-H, Yang J-S, Bergelson LD, and Ferretti JA: Interaction of peptide fragment 828-848 of the envelope glycoprotein of human immunodeficiency virus type I with lipid bilayers. Biochemistry 1993;32:3112-3118.
28. Segrest J, Loof H, Dohlman J, Brouillette C, and Anantharamaiah G: Amphipathic helix motif: Classes and properties. Proteins 1990;8:103-117.
29. Malencik DA, and Anderson SR: Effects of calmodulin and related proteins on the hemolytic activity of mellitin. Biochem Biophys Res Comm 1985;130:22-29.
30. Tencza SB, Mietzner TA, and Montelaro RC: Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants. AIDS Res Hum Retroviruses 1997;13:263-269.
31. Srinivas RV, Bernstein H, Oliver C, and Compans RW: Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication. AIDS Res Hum Retroviruses 1994;10:1489-1496.
32. Miller MA, Mietzner TA, Cloyd MW, Robey WG, and Montelaro RC: Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res Hum Retroviruses 1993;9:1057-1066.
33. Dubay JW, Robert SJ, Hahn BH, and Hunter E: Truncation of the Human immunodeficiency virus transmembrane glycoprotein cytoplasmic domain blocks virus infectivity. J Virol 1992;66: 6616-6625.
34. Srinivas S, Srinivas R, Anantharamaiah G, Segrest J, Compans R, and Segrest J: Cytosolic domain of the HIV envelope glycoprotein binds to calmodulin and inhibits calmodulin-regulated proteins. J Biol Chem 1993;268:22895-22899.
35. Bauer CK, Falk T, and Schwarz JR: An endogenous inactivating inward rectifying potassium current in oocytes of Xenopus laevis. Eur J Physiol 96;432:812-820.
36. Lu L, Montrose-Rafizadeh C, Hwang T-C, and Guggino WB: A delayed rectifier potassium current in Xenopus oocytes. Biophys J 1990;57:1117-1123.
37. Shimbo K, Brassard DL, Lamb RA, and Pinto LH: Viral and cellular small integral membrane proteins can modify ion channels endogenous to Xenopus oocytes. Biophys J 1995;69: 1819-1829.
38. Anderson M, Gregory R, Thompson S, Souza D, Paul S, Mulligan R, Smith A, and Welsh M: Demonstration that the CFTR is a chloride channel by alteration of its anion selectivity. Science 1991;253: 202-205.
39. Pinto LH, Holsinger LJ, and Lamb RA: Influenza virus M2 protein has ion channel activity. Cell 1992;69:517-528.
40. Daskal N, Landau EM, and Lass Y: Xenopus oocyte resting potential, muscarinic responses and the role of calcium and cyclic GMP. J Physiol 1984;352:551-574.
41. Lewis RS and Cahalan MD: Ion channels and signal transduction in lymphocytes. Annu Rev Physiol 1990;52:415-430.
42. Tosteson MT, Holmes SJ, Razin M, and Tosteson DC: Melittin lysis of red cells. J Membrane Biol 1985;87:35-44.
43. Fujii Y, Otake K, Tashio M, and Adachi A: Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett 1996;393:93-96.
44. Ulug E, Garry R, and Bose HR Jr: The role of monovalent cation transport in Sindbis virus maturation and release. Virology 1989;172:42-50.
45. Waite MR and Pfefferkorn ER: Inhibition of Sindbis virus production by media of low ionic strength: intracellular events and requirements for reversal. J Virol 1970;5:60-71.
46. Borsa J, Sargent MD, Long DG, and Chapman JD: Extraordinary effects of specific monovalent cations on activation of reovirus transcriptase by chymotrypsin in vitro. J Virol 1973;11:207-217.
47. Dornadula G, Zhang H, Bagasra O, and Pomerantz R: Natural reverse transcription of simian immunodeficiency virus. Virology 1997;227:260-267.
48. Zhang H, Dornadula G, Laughlin M, and Pomerantz R: Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: A molecular mechanism underlying natural endogenous reverse transcriptase. Proc Natl Acad Sci USA 1996;93:12519-12524.
49. Tosteson MT and Chow M: Characterization of ion channels formed by poliovirus in planar lipid membranes. J Virol 1997;71:507-511.
50. Schegel A, Omar A, Jentsch P, Morell A, and Kempf C: Semlikli Forest virus envelope proteins function as proton channels. Biosci Rep 1991;11:243-255.
51. Lucia-Jandris P, Hooper J, and Fields B: Reovirus M2 gene is associated with chromium release from mouse L cells. J Virol 1993;67:5339-5345.
52. Tian P, Estes MK, Hu Y, Ball JM, Zeng CQ, and Schilling WP: The rotavirus nonstructural glycoprotein NSP4 mobilizes Ca2+ from the endoplasmic reticulum. J Virol 1995;69: 5763-5772.
53. Ball JM, Tian P, Zeng CQ-Y, Morris A, and Estes MK: Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein. Science 1996;272:101-104.
54. 53a. Plymale DR, Comardelle AM, Norris CH, Fermin CD, Tencza SB, Mietzner TA, Montelaro RC, and Garry RF: Human immunodeficiency virus type 1 lentivirus lytic peptide 1 effectively induces apoptosis in T-lymphoblastoid cells. (Submitted for publication.)
55. Garry RF and Fermin CD: Viral burden in AIDS. Nature (London) 1993;365:301-302.
56. Liu J, Farmer JD, Lane WS, Friedman WS, Weissman I, and Schreiber SL: Cell 1991;66:807-815.
57. Siekierka JJ: Probing T-cell signal transduction pathways with the immunosuppressive drugs, FK-506 and rapamycin. Immunol Res 1994;13:110-116.
58. Tomich JM: Amphipathic helices in channel-forming structures. In: The Amphipathic Helix (Epand RM, ed). Boca Raton, Florida, CRC Press, 1993, pp. 222-256.
59. Arroya J, Boceta M, Gonzalez E, Michel M, and Carrasco L: Membrane permeabilization by different regions of the human immunodeficiency virus type 1 transmembrane glycoprotein. J Virol 1995;69:4095-4102.
60. Mobley PW, Curtain CC, Kirkpatrick A, Rostamkhani M, Waring AJ, and Gordon LM: The amino terminal peptide of HIV-1 lyses human erythrocytes and CD4+ lymphocytes. Biochem Biophys Acta 1992;1139:251-256.
61. Lamb RA and Pinto LH: Do Vpu and Vpr of human immunodeficiency virus and NB of influenza B virus have ion channel activities in the viral life cycles? Virology 1997;229:1-11.
62. Piller SC, Ewart GD, Premkumar A, Cox GB, and Gage PW: Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc Natl Acad Sci USA 1996;93:111-115.
63. Schubert U, Ferrer-Montiel AV, Oblatt-Montal M, Henklein P, Strebel K, and Montal M: Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett 1996;398:12-18.
64. Sabitier J-M, Vives E, Mabrouk K, Benjouad A, Rochat H, Duval A, Hue B, and Bahraoui E: Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J Virol 1991;65: 961-967.
65. Garry RF and Koch G: Tat contains a sequence related to snake neurotoxins. AIDS 1992;6:1541-1542.
66. Nath A, Psooy K, Martin C, Knudsen B, Magnuson DSK, Haughey N, and Geiger JD: Identification of a human immunodeficiency virus type 1 tat epitope that is neuroexcitatory and neurotoxic. J Virol 1996;70:1475-1480.
67. Werner T, Ferroni S, Saermark T, Brack-Werner R, Banati R, Mager R, Steinaa L, Kreutzberg G, and Erfle V: HIV-1 Nef protein exhibits structural and functional similarity to scorpion peptides interacting with potassium channels. AIDS 1991;5: 1301-1308.